Literature DB >> 23846832

Apoptotic effects of tamoxifen on leukocytes from horse peripheral blood and bronchoalveolar lavage fluid.

J Sarmiento1, B Perez, N Morales, C Henriquez, L Vidal, H Folch, J S Galecio, G Morán.   

Abstract

A reduction in inflammatory cell apoptosis is an important concept in the maintenance of inflammation and a potential target for the resolution of inflammation in many inflammatory diseases. Dysregulation of apoptosis has been implicated in a range of diseases, including tumors, neurodegenerative disorders and autoimmunity, and may also be implicated in allergic asthma. In horses, recurrent airway obstruction (RAO) is an asthma-like condition that is characterized increased survival neutrophil bronchial. Tamoxifen is a synthetic, non-steroidal, anti-estrogen agent that is widely used for treating all stages of breast cancer and has been approved for the prevention of breast cancer in high-risk women. The observed efficacy of tamoxifen has been attributed to both growth arrest and the induction of apoptosis. Therefore, the aim of our study was to evaluate the ability of tamoxifen to induce apoptosis in vitro in granulocytic cells from peripheral blood and in mononuclear cells from bronchoalveolar lavage fluid (BALF) in horses. Flow cytometry using commercial AnnexinV-FITC and propidium iodide was used to quantify early and late apoptotic leukocytes, respectively. The results showed a significant increase in early apoptosis in peripheral blood and bronchial granulocytic cells treated with tamoxifen. The rate of early apoptosis of mononuclear cells from blood and BALF when incubated with tamoxifen was significantly lower compared with granulocytic cells. We did not observe a direct effect of tamoxifen on late apoptosis in any of the in vitro assays in the cell types used here. These results indicate that the apoptotic mechanisms under these experimental conditions would affect only blood and BALF granulocytic cells, particularly in early apoptosis. Finally, further in vitro and in vivo studies are needed to better understand apoptotic mechanisms because tamoxifen could be used to treat chronic, inflammatory pathologies associated with granulocytes and allergic diseases, such as asthma or equine RAO.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846832     DOI: 10.1007/s11259-013-9571-0

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  49 in total

1.  Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen.

Authors:  P E Budtz
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

2.  Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells.

Authors:  Marie Debrue; Emma Hamilton; Philippe Joubert; Stéphane Lajoie-Kadoch; Jean-Pierre Lavoie
Journal:  Vet Immunol Immunopathol       Date:  2005-05-01       Impact factor: 2.046

3.  Time-dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with recurrent airway obstruction.

Authors:  Dorothy M Ainsworth; Bettina Wagner; Marco Franchini; Gabriele Grünig; Hollis N Erb; Jean-Yin Tan
Journal:  Am J Vet Res       Date:  2006-04       Impact factor: 1.156

4.  Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation.

Authors:  B Dibbert; M Weber; W H Nikolaizik; P Vogt; M H Schöni; K Blaser; H U Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes.

Authors:  D A Cameron; J C Keen; J M Dixon; C Bellamy; A Hanby; T J Anderson; W R Miller
Journal:  Eur J Cancer       Date:  2000-05       Impact factor: 9.162

6.  Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme.

Authors:  C A O'Brian; N E Ward; B W Anderson
Journal:  J Natl Cancer Inst       Date:  1988-12-21       Impact factor: 13.506

7.  In vitro bioassay to detect reaginic antibodies from the serum of horses affected with recurrent airway obstruction.

Authors:  Gabriel Morán; Rafael Burgos; Oscar Araya; Hugo Folch
Journal:  Vet Res Commun       Date:  2009-12-10       Impact factor: 2.459

8.  Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation.

Authors:  S Mark Duffy; Wendy J Lawley; Davinder Kaur; Weidong Yang; Peter Bradding
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

9.  Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells.

Authors:  Dorothy M Ainsworth; Gabriele Grünig; Mary Beth Matychak; Jean Young; Bettina Wagner; Hollis N Erb; Douglas F Antczak
Journal:  Vet Immunol Immunopathol       Date:  2003-11-15       Impact factor: 2.046

10.  Effects of in vitro exposure to hay dust on expression of interleukin-17, -23, -8, and -1beta and chemokine (C-X-C motif) ligand 2 by pulmonary mononuclear cells isolated from horses chronically affected with recurrent airway disease.

Authors:  Dorothy M Ainsworth; Bettina Wagner; Hollis N Erb; Jean C Young; Danielle E Retallick
Journal:  Am J Vet Res       Date:  2007-12       Impact factor: 1.156

View more
  8 in total

1.  Tamoxifen induces apoptotic neutrophil efferocytosis in horses.

Authors:  C Olave; N Morales; B Uberti; C Henriquez; J Sarmiento; A Ortloff; H Folch; G Moran
Journal:  Vet Res Commun       Date:  2018-01-02       Impact factor: 2.459

2.  Impaired Cell Cycle Regulation in a Natural Equine Model of Asthma.

Authors:  Alicja Pacholewska; Vidhya Jagannathan; Michaela Drögemüller; Jolanta Klukowska-Rötzler; Simone Lanz; Eman Hamza; Emmanouil T Dermitzakis; Eliane Marti; Tosso Leeb; Vincent Gerber
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

3.  Tamoxifen in horses: pharmacokinetics and safety study.

Authors:  Gonzalo Gajardo; Rodrigo López-Muñoz; Anita Plaza; Benjamin Uberti; José Sarmiento; Gabriel Morán; Claudio Henríquez
Journal:  Ir Vet J       Date:  2019-06-20       Impact factor: 2.146

4.  Tamoxifen and its metabolites induce mitochondrial membrane depolarization and caspase-3 activation in equine neutrophils.

Authors:  Alejandro Albornoz; Natalia Morales; Benjamin Uberti; Claudio Henriquez; Rafael A Burgos; Pablo Alarcon; Gabriel Moran
Journal:  Vet Med Sci       Date:  2020-06-17

5.  Estrogen receptor-α signaling increases allergen-induced IL-33 release and airway inflammation.

Authors:  Jacqueline-Yvonne Cephus; Vivek D Gandhi; Ruchi Shah; Jordan Brooke Davis; Hubaida Fuseini; Jeffrey A Yung; Jian Zhang; Hirohito Kita; Vasiliy V Polosukhin; Weisong Zhou; Dawn C Newcomb
Journal:  Allergy       Date:  2020-07-26       Impact factor: 13.146

6.  Neutrophil and macrophage apoptosis in bronchoalveolar lavage fluid from healthy horses and horses with recurrent airway obstruction (RAO).

Authors:  Artur Niedzwiedz; Zbigniew Jaworski; Bartlomiej Tykalowski; Marcin Smialek
Journal:  BMC Vet Res       Date:  2014-01-24       Impact factor: 2.741

7.  Tamoxifen inhibits chemokinesis in equine neutrophils.

Authors:  Natalia Morales; Claudio Henriquez; Jose Sarmiento; Benjamin Uberti; Gabriel Moran
Journal:  Ir Vet J       Date:  2018-10-23       Impact factor: 2.146

8.  Efficacy of tamoxifen for the treatment of severe equine asthma.

Authors:  Sophie Mainguy-Seers; Khristine Picotte; Jean-Pierre Lavoie
Journal:  J Vet Intern Med       Date:  2018-08-07       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.